Combining enhanced permeability strategies with (2‐pyridyl)methylene substitution in the sulbactam scaffold led to a novel β‐lactamase inhibitor to combat β‐lactamase‐mediated resistance to β‐lactam antibiotics. The studies presented highlight the potential of compound 3 as a next‐generation β‐lactamase inhibitor for combating infections caused by ...
Diana Rodríguez +4 more
wiley +1 more source
Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp) [PDF]
Aloj, F. +10 more
core +1 more source
Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection. [PDF]
Morita J +7 more
europepmc +1 more source
In Vitro Evaluation of the Compatibility of Meropenem and Tanreqing Under Parallel Infusion Conditions. [PDF]
Ren X, Li X, Dong Z.
europepmc +1 more source
Investigating the Effect of Xylitol on <i>ompK36</i> Overexpression, Increased Meropenem Susceptibility, and Antibiofilm Activity in a Carbapenem-Resistant Clinical Strain of <i>Klebsiella pneumoniae</i>. [PDF]
Ahlelyorof O +4 more
europepmc +1 more source
Evidence of intrapulmonary penetration of nacubactam, a novel β-lactamase inhibitor, following coadministration of nacubactam with meropenem in healthy adults. [PDF]
Morita J +7 more
europepmc +1 more source
Extended vs Intermittent Infusion of Meropenem with Colistimethate Sodium and Risk of Acute Kidney Injury in Critically Ill Patients: A Propensity Score-Matched Retrospective Cohort Study. [PDF]
Hu Q, Wang H.
europepmc +1 more source
Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients. [PDF]
Cojutti PG +9 more
europepmc +1 more source

